Literature DB >> 1021543

Reduction of blood platelet serotonin levels in manic and depressed patients.

S Takahashi.   

Abstract

Blood platelet serotonin levels were measured in unmedicated 12 manic and 74 depressive patients with 118 normal control subjects employed. Blood platelets were separated by multiple centrifugation in the medium of Na2-EDTA solution, and the loss of serotonin during collecting procedures was about 11%. The mean value of blood platelet serotonin levels in depressed patients was 594 +/- 288 ng/mg platelet protein (+/- S.D.), which was significantly lower than that for normal controls, 780 +/- 253 ng/mg protein (p less than 0.001). Age does not account for the reduction of serotonin levels both in depressed and in normal population. Unipolar and involutional depressed patients exhibited to have the most pronounced reduced levels of serotonin of various subtypes of depression, while bipolar depressed patients, neurotic and chronic characterological depressed patients as well as patients with first-episode depression had the values which were comparable with those in normal controls. Manic patients did not show enhancement but did reduction of serotonin levels, the mean being 580 +/- 152 ng/mg protein, which made a contrast with their clinical manifestations of exhilaration and hyperactivity. Changes in blood platelet serotonin levels were determined before, during and after administration of L-5-HTP with a maintenance dose of 300 mg daily in nine depressed patients. Serotonin levels in all subjects were lifted to normal levels during the L-5-HTP treatment, while clinical symptoms were not improved with the treatment. Reduction of blood platelet serotonin levels in depressed patients may be due to their psychobiological distinction, which involves abnormal biogenic amine metabolism in the brain.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1021543     DOI: 10.1111/j.1440-1819.1976.tb02670.x

Source DB:  PubMed          Journal:  Folia Psychiatr Neurol Jpn        ISSN: 0015-5721


  9 in total

1.  Maternal age as a potential explanation of the role of the L allele of the serotonin transporter gene in anxiety and depression in Asians.

Authors:  David E Comings; James P MacMurray
Journal:  Neurosci Bull       Date:  2014-06       Impact factor: 5.203

Review 2.  Astrocytes in depression and Alzheimer's disease.

Authors:  Yang Liao; Qu Xing; Qianqian Li; Jing Zhang; Ruiyuan Pan; Zengqiang Yuan
Journal:  Front Med       Date:  2021-11-23       Impact factor: 4.592

3.  Depression and whole blood serotonin in patients with coronary heart disease from the Heart and Soul Study.

Authors:  Lawson R Wulsin; Dominique Musselman; Christian Otte; Erica Bruce; Sadia Ali; Mary A Whooley
Journal:  Psychosom Med       Date:  2009-03-17       Impact factor: 4.312

4.  Human depression: a new approach in quantitative psychiatry.

Authors:  Massimo Cocchi; Lucio Tonello; Mark M Rasenick
Journal:  Ann Gen Psychiatry       Date:  2010-06-03       Impact factor: 3.455

5.  Fatty acids, membrane viscosity, serotonin and ischemic heart disease.

Authors:  Massimo Cocchi; Lucio Tonello; Giovanni Lercker
Journal:  Lipids Health Dis       Date:  2010-09-08       Impact factor: 3.876

6.  Changes in human platelet 5 HT level after 1 week of chlorimipramine treatment.

Authors:  M F Poirier; K H Le Quan-Bui; H Lôo; P Meyer
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

Review 7.  Neuropsychiatric disorders related to interferon and interleukins treatment.

Authors:  Aye Mu Myint; Markus J Schwarz; Harry W M Steinbusch; Brian E Leonard
Journal:  Metab Brain Dis       Date:  2008-12-10       Impact factor: 3.584

8.  Increased platelet serotonin in bipolar depression and hypomania.

Authors:  A Wirz-Justice; W Pühringer
Journal:  J Neural Transm       Date:  1978       Impact factor: 3.575

9.  Depression, osteoporosis, serotonin and cell membrane viscosity between biology and philosophical anthropology.

Authors:  Massimo Cocchi; Lucio Tonello; Fabio Gabrielli; Massimo Pregnolato
Journal:  Ann Gen Psychiatry       Date:  2011-03-30       Impact factor: 3.455

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.